The effect of neutrophils, tumor necrosis factor, and granulocyte macrophage/colony stimulating factor on Babesia bovis and Babesia bigemina in culture
β Scribed by L.J. Tambrallo; G.M. Buening; R.M. McLaughlin
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 711 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0304-4017
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Injection of bacterial endotoxin or granulocyte/macrophage colony-stimulating factor (GM-CSF) into exhypoxic polycythemic mice simultaneously with erythropoietin (EPO) suppressed erythroid cell formation, as monitored by 59Fe incorporation into circulating red blood cells. This effect was dose-depen
## Abstract We previously established 2 lung cancer cell lines, OKaβCβ1 and MIβ4, which constitutively produce an abundant dose of granulocyteβcolony stimulating factor (GβCSF) and granulocyte macrophageβcolony stimulating factor (GMβCSF). Many other cases with GβCSF or GMβCSF producing tumors have
Interleukin 1 and tumor necrosis factor-a additively increase the levels of granulocyte-macrophage and granulocyte colony-stimulating factor (CSF) mRNA in human fibroblasts\* Recombinant interleukin (IL) 1 p and tumor necrosis factorkachectin (TNF-a) induce, usually within 2 h, a dose-dependent incr
Granulocyte-macrophage colony-stimulating factor (GM-CSF) (250 microg/m2) was administered subcutaneously to 7 normal volunteers for up to 14 days to study its effects on neutrophil kinetics and function. With treatment, blood neutrophil counts rose gradually to peak at 3 1/2 times baseline by day 1
GM-CSF is a major regulator of myelopoiesis. Recombinant human GM-CSF (250 micrograms/m2 per day i.v.) was used prior to chemotherapy ("3 + 7" scheme) to recruit leukemic blasts in vivo (de novo AML patients, n = 20) into the chemotherapy sensitive phases of the cell cycle. The stimulatory effect of